What is the recommended treatment for bullous impetigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bullous Impetigo

For bullous impetigo, the recommended treatment is topical mupirocin or retapamulin applied twice daily for 5 days as first-line therapy for limited disease, while oral antibiotics active against Staphylococcus aureus are recommended for extensive disease. 1

Causative Organism

  • Bullous impetigo is caused exclusively by Staphylococcus aureus strains that produce toxins cleaving the dermal-epidermal junction, forming fragile, thin-roofed vesicopustules 1, 2
  • These lesions may rupture, creating crusted, erythematous erosions often surrounded by remnants of the blister roof 1, 3

Treatment Algorithm

For Limited Disease:

  • Topical antibiotics are first-line therapy 1, 4:
    • Mupirocin 2% ointment applied twice daily for 5 days 1, 4
    • Retapamulin applied twice daily for 5 days 1
  • Clinical efficacy rates for mupirocin are significantly higher than placebo (71% vs 35%) 4
  • Topical therapy has fewer side effects than oral antibiotics 5

For Extensive Disease or Multiple Lesions:

  • Oral antibiotics for 7 days are recommended 6, 1
  • For methicillin-susceptible S. aureus (MSSA):
    • Dicloxacillin or cephalexin are first-line options 6, 1
  • For suspected or confirmed MRSA:
    • Doxycycline, clindamycin, or sulfamethoxazole-trimethoprim (SMX-TMP) 6, 1
  • Oral penicillin V is not recommended as it is seldom effective against S. aureus 7

Special Considerations

  • Oral antibiotics should also be considered during outbreaks affecting several people to decrease transmission 1
  • Topical disinfectants are inferior to antibiotics and should not be used 2, 5
  • Monitor for clinical response within 24-48 hours when using oral antibiotics 1
  • If progression occurs despite antibiotics, consider:
    • Infection with resistant organisms 1, 2
    • Presence of a deeper infection than initially recognized 1

Efficacy Comparisons

  • Topical mupirocin has been shown to be slightly superior to oral erythromycin in multiple studies (RR 1.07,95% CI 1.01 to 1.13) 5
  • Mupirocin and fusidic acid have similar efficacy rates 5
  • Topical antibiotics are significantly better than disinfecting treatments (RR 1.15,95% CI 1.01 to 1.32) 5

Antibiotic Resistance Considerations

  • Worldwide, bacteria causing impetigo show growing resistance rates for commonly used antibiotics 5
  • For suspected MRSA infections, clindamycin is helpful 2
  • SMX-TMP covers MRSA but is inadequate for streptococcal infections 2

Bullous impetigo usually resolves within two to three weeks without scarring, and complications are rare, with the most serious being poststreptococcal glomerulonephritis 2.

References

Guideline

Treatment of Bullous Impetigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Impetigo: diagnosis and treatment.

American family physician, 2014

Research

Bacterial diseases of the skin.

Journal of long-term effects of medical implants, 2005

Research

Interventions for impetigo.

The Cochrane database of systematic reviews, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and treatment of impetigo.

American family physician, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.